Palvella Therapeutics Inc (PVLA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 09-2015 | 06-2015 | 03-2015 | 12-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -14,059 | -11,157 | -7,235 | -3,705 | -9,840 |
| Depreciation Amortization | 308 | 234 | 155 | 78 | 360 |
| Accounts receivable | N/A | -17 | N/A | N/A | 465 |
| Accounts payable and accrued liabilities | -91 | -49 | 897 | 441 | 1,116 |
| Other Working Capital | -791 | -635 | -472 | -495 | 590 |
| Other Operating Activity | 1,927 | 1,411 | -21 | 88 | 2,249 |
| Operating Cash Flow | $-12,706 | $-10,213 | $-6,677 | $-3,593 | $-5,060 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -621 | -269 | -74 | -41 | -260 |
| Investing Cash Flow | $-621 | $-269 | $-74 | $-41 | $-260 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 1,210 |
| Debt Repayment | -1,158 | -1,158 | -1,171 | -1,128 | -182 |
| Common Stock Issued | 25,774 | 25,764 | N/A | N/A | 11,963 |
| Other Financing Activity | 0 | 0 | 0 | 0 | 7,338 |
| Financing Cash Flow | $24,616 | $24,606 | $-1,171 | $-1,128 | $20,330 |
| Exchange Rate Effect | -415 | -343 | -525 | -546 | -210 |
| Beginning Cash Position | 18,474 | 18,474 | 18,474 | 18,474 | 3,680 |
| End Cash Position | 29,349 | 32,255 | 10,027 | 13,167 | 18,470 |
| Net Cash Flow | $10,875 | $13,781 | $-8,447 | $-5,307 | $14,780 |
| Free Cash Flow | |||||
| Operating Cash Flow | -12,706 | -10,213 | -6,677 | -3,593 | -5,060 |
| Capital Expenditure | -621 | -269 | -74 | -41 | -267 |
| Free Cash Flow | -13,326 | -10,483 | -6,751 | -3,634 | -5,327 |